ELF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.167700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.469640E-01
Normal-vs-Stage2
1.090240E-01
Normal-vs-Stage3
8.442300E-02
Normal-vs-Stage4
6.576800E-01
Stage1-vs-Stage2
8.081200E-01
Stage1-vs-Stage3
1.311450E-01
Stage1-vs-Stage4
1.651440E-01
Stage2-vs-Stage3
1.498200E-01
Stage2-vs-Stage4
2.758000E-01
Stage3-vs-Stage4
4.141700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.113800E-02
Normal-vs-AfricanAmerican
7.268800E-01
Normal-vs-Asian
1.726800E-01
Caucasian-vs-AfricanAmerican
3.920200E-01
Caucasian-vs-Asian
9.271600E-01
AfricanAmerican-vs-Asian
3.293800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.090300E-02
Normal-vs-Female
8.847900E-02
Male-vs-Female
9.708000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.088600E-01
Normal-vs-Age(41-60Yrs)
2.562000E-01
Normal-vs-Age(61-80Yrs)
4.934300E-02
Normal-vs-Age(81-100Yrs)
4.608000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.942400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.175400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.241200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.813820E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.254210E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.033800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.197700E-02
Normal-vs-Daily Drinker
2.030200E-02
Normal-vs-Weekly Drinker
7.108300E-02
Normal-vs-Occasional Drinker
2.142000E-01
Normal-vs-Social Drinker
7.096200E-02
Non Drinker-vs-Daily Drinker
2.431800E-01
Non Drinker-vs-Weekly Drinker
3.345600E-01
Non Drinker-vs-Occasional Drinker
3.102600E-01
Non Drinker-vs-Social Drinker
9.658800E-01
Daily Drinker-vs-Weekly Drinker
9.673400E-01
Daily Drinker-vs-Occasional Drinker
5.867700E-02
Daily Drinker-vs-Social Drinker
2.927600E-01
Weekly Drinker-vs-Occasional Drinker
1.269620E-01
Weekly Drinker-vs-Social Drinker
3.892600E-01
Occasional Drinker-vs-Social Drinker
4.039000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.986500E-02
Normal-vs-Grade 2
2.657400E-03
Normal-vs-Grade 3
6.241400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.893400E-01
Grade 1-vs-Grade 3
5.552400E-01
Grade 1-vs-Grade 4
9.986500E-02
Grade 2-vs-Grade 3
9.117000E-01
Grade 2-vs-Grade 4
2.657400E-03
Grade 3-vs-Grade 4
6.241400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.575800E-02
Normal-vs-NonDiabetic
4.423800E-02
Diabetic-vs-NonDiabetic
6.657000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.205000E-01
Normal-vs-NoPancreatitis
6.049900E-02
Pancreatitis-vs-NoPancreatitis
1.488170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.000400E-02
Normal-vs-N1
1.165840E-01
N0-vs-N1
1.847240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.297200E-01
Normal-vs-TP53-NonMutant
2.173400E-01
TP53-Mutant-vs-TP53-NonMutant
6.195600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
